210 related articles for article (PubMed ID: 29857955)
1. A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot.
Jansen RB; Svendsen OL
J Diabetes Complications; 2018 Jul; 32(7):708-712. PubMed ID: 29857955
[TBL] [Abstract][Full Text] [Related]
2. Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
Pitocco D; Collina MC; Musella T; Ruotolo V; Caputo S; Manto A; Caradonna P; Galli M; Mancini L; Ghirlanda G
Horm Metab Res; 2008 Mar; 40(3):163-4. PubMed ID: 18256973
[No Abstract] [Full Text] [Related]
3. Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.
Jeffcoate WJ
Curr Diab Rep; 2005 Dec; 5(6):430-5. PubMed ID: 16316593
[TBL] [Abstract][Full Text] [Related]
4. The diabetic Charcot foot.
Dissanayake SU; Bowling FL; Jude EB
Curr Diabetes Rev; 2012 May; 8(3):191-4. PubMed ID: 22429012
[TBL] [Abstract][Full Text] [Related]
5. Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
Das L; Rastogi A; Jude EB; Prakash M; Dutta P; Bhansali A
PLoS One; 2021; 16(11):e0259224. PubMed ID: 34748565
[TBL] [Abstract][Full Text] [Related]
6. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Naqvi A; Cuchacovich R; Saketkoo L; Espinoza LR
Am J Med Sci; 2008 Feb; 335(2):145-8. PubMed ID: 18277124
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
[TBL] [Abstract][Full Text] [Related]
8. Charcot foot in diabetes: farewell to the neurotrophic theory.
Chantelau E; Onvlee GJ
Horm Metab Res; 2006 Jun; 38(6):361-7. PubMed ID: 16823717
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
Selby PL; Young MJ; Boulton AJ
Diabet Med; 1994; 11(1):28-31. PubMed ID: 8181248
[TBL] [Abstract][Full Text] [Related]
10. Acute Charcot neuro-osteoarthropathy.
Petrova NL; Edmonds ME
Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():281-6. PubMed ID: 26451965
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and medical management of diabetic Charcot neuroarthropathy.
Mascarenhas JV; Jude EB
Med Clin North Am; 2013 Sep; 97(5):857-72. PubMed ID: 23992897
[TBL] [Abstract][Full Text] [Related]
13. Neurogenic disorders of the foot in diabetes mellitus.
Kraft E; Spyropoulos E; Finby N
Am J Roentgenol Radium Ther Nucl Med; 1975 May; 124(1):17-24. PubMed ID: 1147159
[TBL] [Abstract][Full Text] [Related]
14. Confronting a dramatic situation: the charcot foot complicated by osteomyelitis.
Dalla Paola L
Int J Low Extrem Wounds; 2014 Dec; 13(4):247-62. PubMed ID: 25123373
[TBL] [Abstract][Full Text] [Related]
15. Acute neuropathic joint disease: a medical emergency?
Jeffcoate WJ; Game FL; Armstrong DG; Cavanagh PR
Diabetes Care; 2006 Apr; 29(4):951-2; author reply 952. PubMed ID: 16602195
[No Abstract] [Full Text] [Related]
16. Teriparatide (recombinant human parathyroid hormone [1-34]) increases foot bone remodeling in diabetic chronic Charcot neuroarthropathy: a randomized double-blind placebo-controlled study.
Rastogi A; Hajela A; Prakash M; Khandelwal N; Kumar R; Bhattacharya A; Mittal BR; Bhansali A; Armstrong DG
J Diabetes; 2019 Sep; 11(9):703-710. PubMed ID: 30632290
[TBL] [Abstract][Full Text] [Related]
17. Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.
Schmidt BM; Holmes CM
Curr Diab Rep; 2018 Aug; 18(10):74. PubMed ID: 30112582
[TBL] [Abstract][Full Text] [Related]
18. Management of the diabetic Charcot foot.
Frykberg RG; Mendeszoon E
Diabetes Metab Res Rev; 2000; 16 Suppl 1():S59-65. PubMed ID: 11054891
[TBL] [Abstract][Full Text] [Related]
19. Medical image. A sequel of deranged metabolic control. Diabetes mellitus.
Kumar N; Cheung YC; Varughese GI; Benn JJ; Willis AC
N Z Med J; 2008 Jan; 121(1268):U2900. PubMed ID: 18256715
[No Abstract] [Full Text] [Related]
20. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.
Molines L; Darmon P; Raccah D
Diabetes Metab; 2010 Sep; 36(4):251-5. PubMed ID: 20570543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
